Implementation of an osteoporosis research program with a mobile dual-energy X-ray absorptiometry unit: The Montana/Wyoming experience

Osteoporosis International

Volumn 7, Issue 6, 1997, Pages 583-588

  Ulrich, U ^a   Browning, M ^b   Gaffney, E V ^b   Schoter K H ^c   Chesnut III, C H ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Deaconess Research Institute   (United States)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Bisphosphonates; Dual energy X ray absorptiometry; Ibandronate; Osteoporosis; Rural clinical research

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID;

ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; MEASUREMENT; MEDICAL RESEARCH; OSTEOPOROSIS; PHANTOM; PRIORITY JOURNAL; RURAL AREA; UNITED STATES;

EID: 0031456682     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02652566     Document Type: Article

References (16)

1. Riggs BL, Melton LJ. Involutional osteoporosis. N Engl J Med 1986;14:1676-86
2. Notelovitz M. Osteoporosis: screening, prevention, and management. Fertil Steril 1993;59:707-25.
3. Pak CY, Sakhaee K, Adams-Huet B, Piziak V, Peterson RD, Poindexter JR. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride: final report of a randomized controlled trial. Ann Intern Med 1995;123:401-8.
4. Chesnut CH III, McClung MR, Ensrud KE, et al. Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodelling. Am J Med 1995;99:144-52.
5. Liberman UA, Weiss SR, Broll JB, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures on postmenopausal osteoporosis. N Engl J Med 1995;333:1437-43.
6. English S, Hamilton C, Carlson-Fisher B, Leitheiser J, Browning M, Chesnut C III. Feasibility of collaborations between university academic centers in the performance of osteoporosis clinical trials. In: Christiansen C, editor. Proceedings of the 4th International Symposium on Osteoporosis. Hong-Kong: Gardiner-Caldwell Communications, 1993:128.
7. Chesnut CH III. Noninvasive methods for bone mass measurement. In: Avioli LN, editor. The osteoporotic syndrome, 3rd ed. New York: Wiley-Liss, 1993:77-87.
8. Mazess R, Chesnut CH III. McClung M, Genant HK. Enhanced precision with dual-energy X-ray absorptiometry. Calcif Tissue Int 1992;51:14-7.
9. Steiger P, Cummings SR, Genant HK, Weiss H. Morphometric x-ray absorptiometry of the spine: correlation in vivo with morphometric radiography. Osteoporos Int 1994;4:238-44.
10. Lang T, Takada M, Gee R, et al. A preliminary evaluation of the Lunar Expert-XL for bone densitometry and vertebral morphometry. J Bone Miner Res 1997;12:136-43.
11. Swaddiwudhipong W, Chaovakiratipong C, Nguntra P, Mahsakpan P, Lerdlukanavonge P, Koonchote S. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women. Int J Epidemiol 1995;24:493-8.
12. Thompson CJ, Leese GP. The evaluation of mobile screening for diabetic retinopathy. Scot Med J 1995;40:5-7.
13. Turnbull D, Irwig L, Simpson JM, Donnelly N, Mock P. A prospective cohort study investigating psychosocial predictors of attendance at a mobile breast screening service. Aust J Public Health 1995;19:172-6.
14. McCoy CB, Khoury EL, Hermanns LS, Bankston L. Mobile mammography: a model program for medically underserved women. Womens Health Issues 1992;2:196-203.
15. Takeda I, Nishinaka M, Hirooka S, Onoue Y, Yamada M, Imose K. Mass screenings for osteoporosis using computed X-ray densitometry (CXD) in a mobile unit. Jpn J Public Health 1995;42:379-84.
16. Wapniarz M, Lehmann R, Randerath O, et al. Precision of dual X-ray absorptiometry and peripheral computed tomography using mobile densitometry units. Calcif Tissue Int 1994;54:219-23.